0 likes1 view

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

The fate of President Joe Biden’s landmark climate legislation, the Inflation Reduction Act, is...

Elon Musk’s Department of Government Efficiency (DOGE) has announced plans to collaborate with...

Crypto prices today are showing bearish momentum as Bitcoin (BTC) fell below $96,000. BTC and ETH...

The Ton ecosystem is soaring and having a good Ton wallet is your gateway to joining the action....

After trending down in 2023, nickel prices climbed to a 10 month high in late May of this year....

Westgold Resources (ASX:WGX,TSX:WGX,OTCQX:WGXRF) has completed a scoping study that evaluates an...